Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients
ISRCTN ISRCTN62699180
ClinicalTrials.gov identifier
Public title Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Severe brain injury can lead to a brain edema with increased intracranial pressure. This fact leads to a reduced cerebral blood flow and cerebral oxygenation. These situations can extend the brain edema with a possible poor patient outcome.

7.2% hypertonic saline hydroxyethyl starch 200/0.5 is more effective compared to mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Increased intracranial pressure
Participants - inclusion criteria 1. Neurosurgical patients >18 years with severe neuronal damage being at risk of increased intracranial pressure (ICP)
2. Cerebral edema - visualized by computed tomography (CT) scan, continuous monitoring of ICP
Participants - exclusion criteria Exclusion criteria were elevated ICP due to space occupying lesions with indication for neurosurgical intervention, severe renal failure, metabolic disorders, initial serum sodium >150 mmol/l and initial serum osmolarity >320 mosm/kg
Anticipated start date 01/02/2003
Anticipated end date 31/08/2004
Status of trial Completed
Patient information material
Target number of participants 40
Interventions Cerebral perfusion pressure (CPP) directed therapy with CPP >70 mmHg, sedation, normoventilation.

If ICP >20 mmHg patients receive either 7.2% hydroxyethyl starch 200/0.5 or mannitol 15%.
Primary outcome measure(s) ICP <15 mmHg
Secondary outcome measure(s) Survival, discharge status
Sources of funding Self-funded trial, Department of Anesthesia and Critical Care, Martin-Luther University Halle (Germany)
Trial website
Publications Results: http://www.ncbi.nlm.nih.gov/pubmed/16277715
Contact name Dr  Jens  Soukup
  Address Martin-Luther-University Halle
Department of Anaesthesia and Critical Care
Klinikum Kröllwitz
Ernst-Grube-Str. 40
  City/town Halle
  Zip/Postcode 06097
  Country Germany
  Tel +49 345 5575992
  Fax +49 345 5574636
  Email jens.soukup@medizin.uni-halle.de
Sponsor Martin-Luther-University Halle - Department of Anesthesia and Critical Care (Germany)
  Address Klinikum Kröllwitz
Ernst-Grube-Str. 40
  City/town Halle
  Zip/Postcode 06097
  Country Germany
  Tel +49 345 5575992
  Fax +49 345 5574636
  Email jens.soukup@medizin.uni-halle.de
  Sponsor website: http://www.experimentelle-anaesthesie.de
Date applied 23/06/2005
Last edited 15/04/2008
Date ISRCTN assigned 24/06/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central